Takeda Cambridge in Second Deal to Expand Use of Dimerix Bioscience’s GPCR-HIT Platform
4/13/2011 10:30:59 AM
PERTH, Australia--(BUSINESS WIRE)--Dimerix Bioscience Pty Ltd today announced that it has entered into a second research program with Takeda Cambridge Limited, a UK based subsidiary of Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company. This new program is in addition to the continuing research program announced on 15 April 2010.
comments powered by